Benadryl springs into allergy season
This article was originally published in The Tan Sheet
Executive Summary
New ads for Warner-Lambert's Benadryl allergy products touting effectiveness compared to Rx remedies broke March 13 with a 30-second TV spot. "It may surprise you to know, medical studies prove histamine-blocking Benadryl to be a full 54% more effective than the leading prescription," the ad claims. Allergy drug maker Schering-Plough compared its Rx antihistamine Claritin to OTCs such as Benadryl last year, claiming Claritin does not cause drowsiness (1"The Tan Sheet" Jan. 4, 1999, p. 7). W-L extended Benadryl recently with Children's Fastmelt (2"The Tan Sheet" March 13, p. 8)
You may also be interested in...
Benadryl Children's Allergy/Cold Line Adding Fastmelt Quick-Dissolve Form
Warner-Lambert is welcoming the upcoming allergy season with a new extension to its Benadryl line. Children's Allergy/Cold Fastmelt tablets are set to appear on shelves in mid-March.
Claritin DTC Ad Spend Totals $148 Mil. In Recent 12 Months - Scott-Levin
Schering-Plough spent $148 mil. on direct-to-consumer advertising for its market-leading prescription allergy drug Claritin in the 12 months ended September, according to data from the market research firm Scott-Levin.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC